Inside this issueCover stories“What else would you do with money?”New endowment honors a spirited St. Louis “symbol of Yale”Gene defect plays a role in early heart diseasePartnershipsForty years of research, teaching and healingStudent-run auction for New Haven charities has a banner yearThe rewards of life on the front linesGrants & contractsPeopleLifelines: Elizabeth BradleyExpert on tumor viruses will direct research at Cancer CenterTwo Yale RNA experts receive Ellison awardsHonoring fifty years of far-reaching scientific influenceScientist wins Wiley Prize for research on protein-foldingOut & aboutHealthAdvances: For better health, can the soft drinks | When cancer is a family affairScienceBuilding new bridges from lab to patientAdvances: Growing out of depression | A closer look at bacterial insurgents |
Tumor virus expert will direct research at Cancer Center
Daniel C. DiMaio, M.D., Ph.D., the Waldemar Von Zedtwitz Professor and vice chair of genetics and professor of therapeutic radiology, has been named scientific director of Yale Cancer Center (YCC). In this new role, DiMaio will broadly oversee all basic science research at the YCC. As director of the YCC’s Molecular Virology Program since 1993, DiMaio has guided collaborations among 17 independent but interactive laboratories with a common interest in cancer. His own laboratory is focused on papillomaviruses, an important cause of human cancers, particularly in women. DiMaio’s research group has explored how these viruses control cell growth and proliferation, revealing potential new drug targets for cancer, and is using the viruses as novel research tools to manipulate the behavior of normal cells. After graduating summa cum laude from Yale College in 1974, DiMaio earned his M.D. and Ph.D. degrees from the Johns Hopkins University School of Medicine. In announcing DiMaio’s appointment, YCC Director and Professor of Dermatology
Richard L. Edelson, M.D., said, “Dan brings a wide range of experience
to this senior leadership role, which is critical to YCC’s efforts to
successfully expand our research initiatives. In addition to his own internationally
recognized scientific accomplishments, he has shaped our Molecular Virology
Program into one which serves as a superb example of first-rate interactive
science.” |
||||
